327 related articles for article (PubMed ID: 24280116)
1. Analysis of time taken to discuss new patients with head and neck cancer in multidisciplinary team meetings.
Mullan BJ; Brown JS; Lowe D; Rogers SN; Shaw RJ
Br J Oral Maxillofac Surg; 2014 Feb; 52(2):128-33. PubMed ID: 24280116
[TBL] [Abstract][Full Text] [Related]
2. Quality assessment of a multidisciplinary tumour meeting for patients with head and neck cancer.
Stalfors J; Lundberg C; Westin T
Acta Otolaryngol; 2007 Jan; 127(1):82-7. PubMed ID: 17364335
[TBL] [Abstract][Full Text] [Related]
3. Head and neck multidisciplinary team meetings: Effect on patient management.
Brunner M; Gore SM; Read RL; Alexander A; Mehta A; Elliot M; Milross C; Boyer M; Clark JR
Head Neck; 2015 Jul; 37(7):1046-50. PubMed ID: 24710807
[TBL] [Abstract][Full Text] [Related]
4. Quality insurance in head and neck cancer multidisciplinary team meetings: A watchful eye on real-life experience.
Guy JB; Benna M; Xia Y; Daguenet E; Ben Mrad M; Jmour O; Vial N; Lelonge Y; Fournel P; Prades JM; Vallard A; Magné N
Oral Oncol; 2019 Apr; 91():35-38. PubMed ID: 30926060
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary clinic care improves adherence to best practice in head and neck cancer.
Kelly SL; Jackson JE; Hickey BE; Szallasi FG; Bond CA
Am J Otolaryngol; 2013; 34(1):57-60. PubMed ID: 23218113
[TBL] [Abstract][Full Text] [Related]
6. Tumour boards/multidisciplinary head and neck cancer meetings: are they of value to patients, treating staff or a political additional drain on healthcare resources?
Westin T; Stalfors J
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):103-7. PubMed ID: 18327027
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary head and neck cancer clinic and adherence with speech pathology.
Starmer H; Sanguineti G; Marur S; Gourin CG
Laryngoscope; 2011 Oct; 121(10):2131-5. PubMed ID: 21826674
[TBL] [Abstract][Full Text] [Related]
8. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
[TBL] [Abstract][Full Text] [Related]
9. Influence of audit on clinical practice: multidisciplinary team data documentation for cutaneous head and neck malignancy.
Natt R; Karkos PD; Karkanevatos A
Am J Otolaryngol; 2010; 31(4):261-5. PubMed ID: 20015766
[TBL] [Abstract][Full Text] [Related]
10. Processes and outcomes of head and neck cancer patients from geographically disparate regions of the UK. A comparison of Scottish and English cohorts.
MacKenzie K; Savage SA; Birchall MA
Eur J Surg Oncol; 2009 Oct; 35(10):1113-8. PubMed ID: 19406610
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).
Shikama N; Sasaki S; Nishikawa A; Koiwai K; Yoshino F; Hirase Y; Kawakami R; Kadoya M; Oguchi M
Radiology; 2003 Sep; 228(3):789-94. PubMed ID: 12954897
[TBL] [Abstract][Full Text] [Related]
12. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature.
Pillay B; Wootten AC; Crowe H; Corcoran N; Tran B; Bowden P; Crowe J; Costello AJ
Cancer Treat Rev; 2016 Jan; 42():56-72. PubMed ID: 26643552
[TBL] [Abstract][Full Text] [Related]
13. Does multidisciplinary videoconferencing between a head-and-neck cancer centre and its partner hospital add value to their patient care and decision-making? A mixed-method evaluation.
van Huizen LS; Dijkstra P; Halmos GB; van den Hoek JGM; van der Laan KT; Wijers OB; Ahaus K; de Visscher JGAM; Roodenburg J
BMJ Open; 2019 Nov; 9(11):e028609. PubMed ID: 31699717
[TBL] [Abstract][Full Text] [Related]
14. Current treatment of head and neck squamous cell cancer.
Belcher R; Hayes K; Fedewa S; Chen AY
J Surg Oncol; 2014 Oct; 110(5):551-74. PubMed ID: 25053506
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of therapy and survival for patients with head and neck cancer treated in the community.
Dansky Ullmann C; Harlan LC; Shavers VL; Stevens JL
Cancer; 2012 Sep; 118(18):4452-61. PubMed ID: 22252676
[TBL] [Abstract][Full Text] [Related]
16. Priorities for the head and neck cancer patient, their companion and members of the multidisciplinary team and decision regret.
Gill SS; Frew J; Fry A; Adam J; Paleri V; Dobrowsky W; Chatterjee S; Kelly CG
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):518-24. PubMed ID: 21550217
[TBL] [Abstract][Full Text] [Related]
17. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF
Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818
[TBL] [Abstract][Full Text] [Related]
18. Do multidisciplinary team meetings make a difference in the management of lung cancer?
Boxer MM; Vinod SK; Shafiq J; Duggan KJ
Cancer; 2011 Nov; 117(22):5112-20. PubMed ID: 21523766
[TBL] [Abstract][Full Text] [Related]
19. [The role of the multidisciplinary team in the diagnosis and treatment of patients with laryngeal and hypopharynx cancer].
Golusiński W; Sówka M; Uczułka R; Golusińska E; Kardach H; Wegner A; Pazdrowski J
Otolaryngol Pol; 2013; 67(4):198-203. PubMed ID: 23911048
[TBL] [Abstract][Full Text] [Related]
20. Quality of life considerations in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Rogers SN; Semple C; Babb M; Humphris G
J Laryngol Otol; 2016 May; 130(S2):S49-S52. PubMed ID: 27841117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
